Selective Wealth Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-160
Closed -$3K 421
2020
Q4
$3K Hold
160
﹤0.01% 324
2020
Q3
$4K Hold
160
﹤0.01% 254
2020
Q2
$5K Hold
160
﹤0.01% 306
2020
Q1
$5K Hold
160
0.01% 210
2019
Q4
$7K Buy
+160
New +$6.65K 0.01% 188

Other funds holding RCEL

Selective Wealth Management's RCEL Position: Q1 2021 in Review

Selective Wealth Management sold out of Avita Medical (RCEL) in Q1 2021, closing a stake of 160 shares — an estimated $3K sold.

Selective Wealth Management first reported a position in RCEL in Q4 2019 and held it in 5 quarters. The position peaked at $7K in Q4 2019. 61 funds tracked by Wall St. Rank hold RCEL as of Q1 2021.

  • Selective Wealth Management reported no remaining Avita Medical position as of Q1 2021 after selling out during the quarter.
  • Selective Wealth Management sold 160 Avita Medical shares in Q1 2021, an estimated $3K.
  • Selective Wealth Management first reported a position in Avita Medical in Q4 2019 and held it in 5 quarters.
  • Selective Wealth Management's Avita Medical position peaked at $7K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Avita Medical as of Q1 2021.

Based on Selective Wealth Management's 13F filing for Q1 2021, filed 9 Apr 2021.